MARKER THERAPEUTICS, INC. Operating Lease, Payments
MARKER THERAPEUTICS, INC. (MRKR) reported Operating Lease, Payments of $232.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2023-05-15
- MARKER THERAPEUTICS, INC. operating lease, payments for the quarter ending 2023-03-31 was $232.00K, a 26.58% decline year-over-year.
- MARKER THERAPEUTICS, INC. operating lease, payments for the quarter ending 2022-12-31 was $206.00K, a 34.39% decline year-over-year.
- MARKER THERAPEUTICS, INC. operating lease, payments for the quarter ending 2022-09-30 was $267.00K, a 6.64% decline year-over-year.
- MARKER THERAPEUTICS, INC. operating lease, payments for the quarter ending 2022-06-30 was $317.00K, a 32.64% increase year-over-year.
- MARKER THERAPEUTICS, INC. operating lease, payments for fiscal 2022 was $1.11M, a 2.69% increase from fiscal 2021.
- MARKER THERAPEUTICS, INC. operating lease, payments for fiscal 2021 was $1.08M, a 97.98% increase from fiscal 2020.
- MARKER THERAPEUTICS, INC. operating lease, payments for fiscal 2020 was $544.00K, a 141.78% increase from fiscal 2019.
- MARKER THERAPEUTICS, INC. operating lease, payments for fiscal 2019 was $225.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2023-03-31 | $232.00K 10-Q · filed 2023-05-15 | $438.00K derived: sum of 2 quarters · filed 2023-05-15 | $705.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.02M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2022-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $473.00K derived: sum of 2 quarters · filed 2023-03-22 | $790.00K derived: sum of 3 quarters · filed 2023-03-22 | $1.11M 10-K · filed 2023-03-22 | |
| 2022-09-30 | $267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $584.00K derived: sum of 2 quarters · filed 2022-11-10 | $900.00K 10-Q · filed 2022-11-10 | $1.21M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2022-06-30 | $317.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $633.00K 10-Q · filed 2022-08-11 | $947.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.23M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2022-03-31 | $316.00K 10-Q · filed 2023-05-15 | $630.00K derived: sum of 2 quarters · filed 2023-05-15 | $916.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.16M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $600.00K derived: sum of 2 quarters · filed 2023-03-22 | $839.00K derived: sum of 3 quarters · filed 2023-03-22 | $1.08M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $286.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $525.00K derived: sum of 2 quarters · filed 2022-11-10 | $763.00K 10-Q · filed 2022-11-10 | $945.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $477.00K 10-Q · filed 2022-08-11 | $659.00K derived: sum of 3 quarters · filed 2022-08-11 | $773.00K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $238.00K 10-Q · filed 2022-05-13 | $420.00K derived: sum of 2 quarters · filed 2022-05-13 | $534.00K derived: sum of 3 quarters · filed 2022-05-13 | $725.00K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $296.00K derived: sum of 2 quarters · filed 2022-03-17 | $487.00K derived: sum of 3 quarters · filed 2022-03-17 | $544.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $305.00K derived: sum of 2 quarters · filed 2021-11-10 | $362.00K 10-Q · filed 2021-11-10 | $225.00K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $191.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $248.00K 10-Q · filed 2021-08-10 | $111.00K derived: sum of 3 quarters · filed 2021-08-10 | ||
| 2020-03-31 | $57.00K 10-Q · filed 2021-05-12 | -$80.00K derived: sum of 2 quarters · filed 2021-05-12 | |||
| 2019-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $225.00K 10-K · filed 2021-03-09 | |||
| 2019-09-30 | $362.00K 10-Q · filed 2020-11-09 | $168.00K 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $111.00K 10-Q · filed 2019-08-09 | $167.00K derived: sum of 2 quarters · filed 2019-08-09 | |||
| 2019-03-31 | $56.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |